NCT05294393View on ClinicalTrials.gov

Ropivacaine Plus Magnesium Sulphate Infiltration

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

January 18, 2024

Study Completion Date

January 18, 2024

Conditions
Thyroid DiseasesParathyroid DiseasesPostoperative PainAnesthesia, Local
Interventions
DRUG

Placebo Comparator: N/S 0.9%

12 ml N/S 0.9% at the end of surgery

DRUG

Ropivacaine 10%

12 ml solution of 100mg ropivacaine at the end of surgery

DRUG

Ropivacaine 10% plus magnesium sulphate 10mg/kg

12 ml solution of 100mg ropivacaine plus magnesium sulphate 10mg/kg at the end of surgery

Trial Locations (1)

54636

Aristotle University, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER